European Journal of Epidemiology

, Volume 9, Issue 3, pp 255–262 | Cite as

A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam

  • E. J. C. van Ameijden
  • J. A. R. Van Den Hoek
  • G. H. C. Mientjes
  • R. A. Coutinho


In the present study data on the incidence of HBV and HCV were used to indicate the prevalence of and trends in risk behavior, assuming that drug users (DUs) who become infected with HBV or HCV are also at risk for infection with HIV. In addition, we determined to that extent the transmission patterns of HIV, HBV and HCV differed. DUs were selected from a cohort study in Amsterdam, had at least one follow-up visit between December 1985 and September 1989 and reported never to have had homosexual contacts. Among 305 DUs, of whom 70% injected recently, the prevalence of HIV, HBV and HCV were 31%, 68% and 65% respectively. These prevalences were strongly interrelated and the same risk factors were found. The cumulative incidence of either HIV or HBV or HCV was 30% among prevalent HIV-negatives. Despite a previously reported reduction in risk behavior, only the HIV incidence tended to decrease initially, and after 1986 the incidences of HIV, HBV and HCV remained disturbingly high and stable (mean: 4, 9 and 10 per 100 person-years, respectively). As at present HBV appears to be transmitted more heterosexually than HIV in our study group and the HIV-epidemic may follow the HBV-epidemic in its transmission patterns, preventive activities targeted at both injecting and sexual behavior should be expanded.

Key words

Human immunodeficiency virus Surveillance Hepatitis B virus Hepatitis C virus Substance abuse, intravenous Risk factors Incidence Follow-up studies The Netherlands 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    AlexanderN.J. (1990): Sexual transmission of human immunodeficiency virus: virus entry into the male and female tract - Fertil. Steril. 54: 1–18.Google Scholar
  2. 2.
    AlterH.J., PurcellR.H., ShihJ.W., MelpolderJ.C., HoughtonM., ChooQ.L. and KuoG. (1989): Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis - N. Engl. J. Med. 321: 1494–1500.Google Scholar
  3. 3.
    AlterM.J., ColemanP.J., AlexanderW.J., KramerE., MillerJ.K., MandelE., HadlerS.C. and MargolisH.S. (1989): Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis - JAMA 262: 1201–1205.Google Scholar
  4. 4.
    AlterM.J., HadlerS.C., JudsonF.N., et al. (1990): Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection - JAMA 264: 2231–2235.Google Scholar
  5. 5.
    AmeijdenE.J.C.van, HoekJ.A.R.van den, HaastrechtH.J.A.van and CoutinhoR.A. (1992): The harm reduction approach and risk factors for HIV seroconversion in injecting drug users, Amsterdam -Am. J. Epidemiol. Vol. 136: 136–143.Google Scholar
  6. 6.
    BlowerS. (1991): Behaviour Change and stabilization of seroprevalence in communities of injecting drug users: correlation or causation? - J. AIDS 4: 920–923.Google Scholar
  7. 7.
    BuningE.C., CoutinhoR.A., BrusselG.H.A.van, SantenG.W.van and ZadelhofA.W.van (1986): Preventing AIDS in drug addicts in Amsterdam (letter) - Lancet 65: 146–150.Google Scholar
  8. 8.
    ChamotE., HirschelB., WintschJ., RobertC.F., GarielV., DeglonJ.J., YerlyS. and PerrinL. (1990): Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users - AIDS 4: 1275–1277.Google Scholar
  9. 9.
    CoombsR.W., CollierA.N., AllainJ.P., NikoraB., LeutherM., GjersetG.F. and CoreyL. (1989): Plasma viremia in human immunodeficiency virus infection- N. Engl. J. Med. 321: 1626–1631.Google Scholar
  10. 10.
    DoornumG.J.J.van, HooykaasC., CuypersM.T., LindenM.M.D.van der and CoutinhoR.A. (1991): Prevalence of hepatitis C virus infection among heterosexuals with multiple partners - J. Med. Virol. 35: 22–27.Google Scholar
  11. 11.
    EstebanJ.I., ViladominL., GonzalesA., et al. (1989): Hepatitis C virus antibodies among risk groups in Spain - 2: 294.Google Scholar
  12. 12.
    Giancario E., De Sanctis G.M., Barbacini LG., Bianchi P., Russini M., Vassiliov V. and Chircu L.V. (1991): Viral hepatitis markers in HIV positive patients —Presented at the Seventh International Conference on AIDS, Florence, Italy M.B. 2205.Google Scholar
  13. 13.
    HaastrechtH.J.A.van, HoekJ.A.R.van den, BardouxC., Leentvaar-KuypersA. and CoutinhoR.A. (1991): The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands - Am. J. Public Health 81: 59–62.Google Scholar
  14. 14.
    HaganH., ReidT., DesJarlaisC., PurchaseD., FriedmanS.R. and BellT.A. (1991): The incidence of HBV infection and syringe exchange programs -JAMA 266: 1646–1647.Google Scholar
  15. 15.
    HartG.J., WoodwardN., JhonsonA.M., TigheJ., ParryJ.V. and AdlerM.W. (1991): Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle-exchange in central London - AIDS 5: 543–547.Google Scholar
  16. 16.
    HartgersC., SantenG.W.van, HaastrechtH.J.A.van, HoekJ.A.R.van den, AkkerR.van den and CoutinhoR.A. (1992): De HIV-prevalentie onder druggebruikers die methadon verstrekt krijgen bij de drugsafdeling van de GG&GD to Amsterdam - T. Soc. Gezondheidsz. 70: 275–279.Google Scholar
  17. 17.
    HayashiP.H., FlynnN., McCurdyS.A., KuramotoI.K., HollandP.V. and ZeldisJ.B. (1991): Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus - J. Med. Vir. 33: 177–180.Google Scholar
  18. 18.
    HigginsD.L., GalavottiC., O'ReillyK.R., et al. (1991): Evidence for the effects of HIV antibody counseling and testing on risk behaviors - JAMA 266: 2419–2429.Google Scholar
  19. 19.
    HoekJ.A.R.van den, CoutinhoR.A., HaastrechtH.J.A.van, ZadelhofA.W.van and GoudsmitJ. (1988): Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam -AIDS 2: 55–60.Google Scholar
  20. 20.
    HoekJ.A.R.van den, HaastrechtH.J.A.van and CoutinhoR.A. (1989): Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS - Am. J. Public Health 79: 1355–1357.Google Scholar
  21. 21.
    HoekJ.A.R.van den, HaastrechtH.J.A.van, GoudsmitJ., and CoutinhoR.A. (1990): Prevalence, Incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam - J. Infect. Dis. 162: 823–826.Google Scholar
  22. 22.
    HolodniyM., KatzensteinD.A., SenguptaS., et al. (1991): Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction - J. Infect. Dis. 163: 862–866.Google Scholar
  23. 23.
    HooykaasC., PlichtJ.van der, DoornumG.J.J.van, LindenM.M.D.van der and CoutinhoR.A. (1989): Heterosexuals at risk for HIV: differences between private and commercial partners in sexual behavior and condom use - AIDS 3: 525–532.Google Scholar
  24. 24.
    HorsburghC.R., JasonJ., LonginiI.M., et al. (1989): Duration of human immunodeficiency virus infection before detection of antibody - Lancet 2: 637–640.Google Scholar
  25. 25.
    MarcellinP., Martinot-PeignouxM., BoyerN., PounteauM., AmountP., ErlingerS. and BenhamouJ.P. (1991): Second generation (RIBA) test in diagnosis of chronic hepatitis C - Lancet 337: 551–552.Google Scholar
  26. 26.
    MeleA., RezzaG., Stazi MagillO.W. and PasquiniP. (1990): Incidence of acute hepatitis B in injecting drug users as an indicator of continuing HIV transmission. International implications - AIDS 4: 598–599.Google Scholar
  27. 27.
    MerminJ.H., HolodniyM., KatzensteinD.A. and MeriganT.C. (1991): Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction - J. Infect. Dis. 164: 769–772.Google Scholar
  28. 28.
    MortimerP.P., CohenB.J., LittonP.A., VanderveldeE.M., BassendineM.F., BrindA.M. and HamblingM.H. (1989): Hepatitis C virus antibody - Lancet 2: 798.Google Scholar
  29. 29.
    NicolosiA., MusiccoM., SaraccoA., MolinariS., ZilianiN. and LazzarinA. (1990): Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and Northern Italy, 1987–1989 - Epidemiology 1: 453–459.Google Scholar
  30. 30.
    PachuckiC.T., LentinoJ.R., SchaafD., SchaeferM.R., HeynenC.A., HolzerT.J., DawsonG.J. and DorusW. (1991): Low prevalence of sexual transmission of hepatitis C virus in sex partners of seropositive intravenous drug users - J. Infect. Dis. 164: 820–821.Google Scholar
  31. 31.
    PoelC.L.van der, ReesinkH.W., SchaarbergW., Leentvaar-KuypersA., BakkerE., Exel-DehlersP.J. and LelieP.N. (1990): Infectivity of blood seropositive for hepatitis C virus antibodies - Lancet 335: 558–560.Google Scholar
  32. 32.
    RobinsonW.S. (1990): Hepatitis B virus and hepatitis delta virus. In: Mandell G.L., Douglas R.G., Bennet J.E., eds. Principles and practice of infectious diseases - 3rd ed. New York: Churchill Livingstone Inc. pp. 1204–1231.Google Scholar
  33. 33.
    RoggendorfM., DeinhartF., RasshoferR., et al. (1989): Antibodies to hepatitis C virus among German blood donors - Lancet 2: 324.Google Scholar
  34. 34.
    Sherlock C., Sibau L., Cook D., Middleton P. and Gill P. (1991): Association between hepatitis C (HCV) antibody and HIV antibody in high risk groups for HIV infection — Presented at the Seventh International Conference on AIDS, Florence, Italy M.B. 2230.Google Scholar
  35. 35.
    SimmondsP., LainsonF.A.L., CuthbertR., SteelC.M., PeuthererJ.F. and LudlamC.A. (1987): HIV infection and antibody detection: variable responses to infection in the Edinburgh haemophilic cohort - Br. Med. J. 296: 593–598.Google Scholar
  36. 36.
    TaylorF. (1991): Decline in hepatitis B cases - Am. J. Public Health 81: 221–222.Google Scholar
  37. 37.
    TorJ., LlibreJ.M., GarbonellM., et al. (1990): Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV - Br. Med. J. 301: 1130–1133.Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • E. J. C. van Ameijden
    • 1
  • J. A. R. Van Den Hoek
    • 1
  • G. H. C. Mientjes
    • 1
  • R. A. Coutinho
    • 1
  1. 1.The Department of Public Health and EnvironmentMunicipal Health ServiceAmsterdamThe Netherlands

Personalised recommendations